.png)
2026 life sciences
career fair
April 9, 2026
Thank you to everyone who came to the career fair! We look forward to welcoming you again next year!
General Event Information
Location: 101 College Street, New Haven, CT
Date: April 9th, 2026
Time: 12:45pm-5pm
Event will include a Keynote Speech from Dr. Robert Plenge of Bristol Myers Squibb, a Panelist Talk with experts in biotechnology, and opportunities to meet with companies at Networking Booths and Tables.
Our Keynote Speaker
Dr. Robert Plenge
Executive Vice President and Chief Research Officer Bristol Myers Squibb
Robert Plenge, MD, PhD, executive vice president, chief research officer, leads scientific activities across nine research sites around the world, all focused on transforming patients’ lives through science.
Prior to his current role, Robert served as head of Discovery & Translational Sciences at BMS, a role that spanned all therapeutic areas at the company. Robert joined BMS as part of the Celgene acquisition in November 2019. At Celgene, he served as vice president, Immunology & Inflammation portfolio, Research & Early Development. Prior to joining Celgene, Robert was vice president and Head of Translational Medicine at Merck.
Robert received his MD and PhD from Case Western Reserve University and holds a BS from the University of California, San Diego. He completed his internal medicine residency as a molecular medicine fellow at the University of California, San Francisco. He served as rheumatology fellow at Brigham & Women’s Hospital and postdoctoral research fellow at the Broad Institute of MIT and Harvard. He was an assistant professor of medicine at Harvard Medical School and an associate member of the Broad Institute while practicing clinical rheumatology and running a research laboratory at Brigham & Women’s Hospital.
Robert is an author of more than 125 manuscripts published in peer-reviewed journals, and frequently posts updates to his personal blog, Plenge Gen, commenting on critical discovery moments with a focus on the resulting patient impact. He is a recipient of several academic and corporate awards and currently serves on the Board of Directors for Alltrna and the PhRMA Foundation.
Meet Our Sponsors
As a leading firm in intellectual property, Finnegan's work spans the full range of IP needs related to European, German, UK, and U.S. IP law. Finnegan also provides counseling and litigation services in advertising, privacy, and a wide spectrum of additional IP-adjacent commercial matters.
Bexorg is a biotech startup working on a perfusion device and blood analog for organ recovery. Operations include but are not limited to (1) manufacturing and assembly of machines, software, and biofluids/proteins, and (2) research services with data as a product.
LambdaVision is leveraging space to develop the first protein-based artificial retina to restore meaningful vision for patients who are blind or have lost significant sight due to advanced retinal degenerative diseases, including retinitis pigmentosa (RP) and age-related macular degeneration (AMD).
Built on a legacy of turning pioneering science into transformative treatments, Alexion listens to and partners with the rare disease ecosystem to help improve outcomes for more people impacted by rare diseases across the globe.
Yale Ventures seeks to foster and accelerate a vibrant entrepreneurship and innovation ecosystem that increases support, resources, and opportunities for Yale innovators as they translate their ideas into new ventures for the world's greatest challenges.
Soleus Capital is a healthcare investment firm focused on the innovative areas of life sciences, including biotech, medtech, diagnostics, and genomics. We invest across the healthcare lifecycle from developmental-stage companies through commercial companies.
Gestalt delivers clinically proven digital pathology solutions that give healthcare organizations confidence in every diagnosis. Gestalt enables care teams to deliver answers faster — so patients receive the right treatment at the right time.
The Yale BBS Development and Involvement Community (YBDIC) is committed to fostering the intellectual and personal growth of students in the BBS.
BioMed X accelerates the pace of innovation in biomedical research and drug discovery & development by combining the best of both worlds – academia and industry.